Prof. Dr. med. Dr. med. habil.
Kai Deusch
 

(M.D. PhD.)

                     

        

Interim CEO

e.g. Riemser Pharma GmbH (G); IInnonix (HK), MAST (USA), 

Entrepreneur

Founder, Owner & CEO of Medicis Group of Companies

Professional Board Member

Riemser Pharma, Medicis portfolio companies

Private Equity Specialist

Former Partner at Apax Partners, Head of Healthcare DACH Region

M & A Expert

e.g. Megapharm/Alliance Boots Transaction

Strategy Consultant

 McKinsey & Co. (Germany)

Prof. Degree Internal Medicine/Immunology

PD Dr. med. Dr.med. habil.
Technical University Munic

Current University Appointment

Adjunct Professor of Medicine, Translational Medicine, University of Toronto (Canada)

Experienced Internist &  Researcher

>14y in academic medicine

  • Harvard Medical School, Dana Farber Cancer Institute & Tufts University (NEMC)
  • Univ. Minnosota, Mainz, London
  • specialized in Immunology, Oncology GI, Hepatol.
  • B.Sc in Biology, Univ. Minnesota